• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双层方法鉴定了由 miR-122 调控的与癌症和肝脏疾病相关的基因网络。

Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122.

机构信息

Center for Systems and Synthetic Biology, Institute for Cellular and Molecular Biology, University of Texas, Austin, Texas 78712, USA.

出版信息

J Biol Chem. 2011 May 20;286(20):18066-78. doi: 10.1074/jbc.M110.196451. Epub 2011 Mar 14.

DOI:10.1074/jbc.M110.196451
PMID:21402708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3093880/
Abstract

MicroRNAs function as important regulators of gene expression and are commonly linked to development, differentiation, and diseases such as cancer. To better understand their roles in various biological processes, identification of genes targeted by microRNAs is necessary. Although prediction tools have significantly helped with this task, experimental approaches are ultimately required for extensive target search and validation. We employed two independent yet complementary high throughput approaches to map a large set of mRNAs regulated by miR-122, a liver-specific microRNA implicated in regulation of fatty acid and cholesterol metabolism, hepatitis C infection, and hepatocellular carcinoma. The combination of luciferase reporter-based screening and shotgun proteomics resulted in the identification of 260 proteins significantly down-regulated in response to miR-122 in at least one method, 113 of which contain predicted miR-122 target sites. These proteins are enriched for functions associated with the cell cycle, differentiation, proliferation, and apoptosis. Among these miR-122-sensitive proteins, we identified a large group with strong connections to liver metabolism, diseases, and hepatocellular carcinoma. Additional analyses, including examination of consensus binding motifs for both miR-122 and target sequences, provide further insight into miR-122 function.

摘要

MicroRNAs 作为重要的基因表达调控因子,通常与癌症等疾病的发育、分化有关。为了更好地了解它们在各种生物过程中的作用,有必要识别 microRNA 靶向的基因。尽管预测工具在这项任务中提供了很大的帮助,但最终还是需要实验方法来进行广泛的目标搜索和验证。我们采用了两种独立但互补的高通量方法来绘制一组由 miR-122 调节的大量 mRNA 图谱,miR-122 是一种在脂肪酸和胆固醇代谢、丙型肝炎感染和肝细胞癌的调节中起作用的肝脏特异性 microRNA。基于荧光素酶报告基因筛选和shotgun 蛋白质组学的组合,鉴定了至少一种方法中 260 种对 miR-122 反应显著下调的蛋白质,其中 113 种含有预测的 miR-122 靶位点。这些蛋白质富含与细胞周期、分化、增殖和凋亡相关的功能。在这些 miR-122 敏感蛋白中,我们鉴定了一大组与肝脏代谢、疾病和肝细胞癌密切相关的蛋白。包括对 miR-122 和靶序列的共识结合基序的进一步分析,为 miR-122 的功能提供了更深入的了解。

相似文献

1
Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122.双层方法鉴定了由 miR-122 调控的与癌症和肝脏疾病相关的基因网络。
J Biol Chem. 2011 May 20;286(20):18066-78. doi: 10.1074/jbc.M110.196451. Epub 2011 Mar 14.
2
MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.miR-450b-3p 通过靶向磷酸甘油酸激酶 1 抑制肝癌细胞生长。
J Cell Biochem. 2019 Nov;120(11):18805-18815. doi: 10.1002/jcb.29196. Epub 2019 Jun 21.
3
miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL.微小RNA-3117通过靶向PHLPPL调节肝癌细胞增殖。
Mol Cell Biochem. 2017 Jan;424(1-2):195-201. doi: 10.1007/s11010-016-2855-2. Epub 2016 Nov 7.
4
miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma.miR-206 通过下调肝癌中的 PTP1B 抑制细胞增殖、侵袭和迁移。
Biosci Rep. 2019 May 15;39(5). doi: 10.1042/BSR20181823. Print 2019 May 31.
5
MiR-221 Promotes Hepatocellular Carcinoma Cells Migration via Targeting PHF2.miR-221 通过靶向 PHF2 促进肝癌细胞迁移。
Biomed Res Int. 2019 May 12;2019:4371405. doi: 10.1155/2019/4371405. eCollection 2019.
6
miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3).miR-490-3p 通过靶向内质网-高尔基体中间区蛋白 3(ERGIC3)调节肝癌细胞的细胞生长和上皮间质转化。
J Biol Chem. 2013 Feb 8;288(6):4035-47. doi: 10.1074/jbc.M112.410506. Epub 2012 Dec 4.
7
MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.微小RNA-500a通过转录后靶向BID促进肝细胞癌进展。
Cell Physiol Biochem. 2018;47(5):2046-2055. doi: 10.1159/000491472. Epub 2018 Jul 3.
8
Suppression of MicroRNA-7 (miR-7) Biogenesis by Nuclear Factor 90-Nuclear Factor 45 Complex (NF90-NF45) Controls Cell Proliferation in Hepatocellular Carcinoma.核因子90-核因子45复合物(NF90-NF45)对微小RNA-7(miR-7)生物合成的抑制作用调控肝细胞癌中的细胞增殖。
J Biol Chem. 2016 Sep 30;291(40):21074-21084. doi: 10.1074/jbc.M116.748210. Epub 2016 Aug 12.
9
Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity.蛋白聚糖 3'-非翻译区(3'-UTR)通过调节 miRNA 活性作为 ceRNA 诱导肝细胞癌的发展。
FASEB J. 2013 Mar;27(3):907-19. doi: 10.1096/fj.12-220905. Epub 2012 Nov 24.
10
MicroRNA-1 promotes apoptosis of hepatocarcinoma cells by targeting apoptosis inhibitor-5 (API-5).微小RNA-1通过靶向凋亡抑制因子5(API-5)促进肝癌细胞凋亡。
FEBS Lett. 2015 Jan 2;589(1):68-76. doi: 10.1016/j.febslet.2014.11.025. Epub 2014 Nov 27.

引用本文的文献

1
Comparison of Mir122 expression in children with biliary atresia and healthy group.胆道闭锁患儿与健康组中Mir122表达的比较。
Mol Biol Res Commun. 2024;13(3):147-154. doi: 10.22099/mbrc.2024.49649.1950.
2
The Circulating Biomarkers League: Combining miRNAs with Cell-Free DNAs and Proteins.循环生物标志物联盟:将 microRNAs 与游离 DNA 和蛋白质相结合。
Int J Mol Sci. 2024 Mar 17;25(6):3403. doi: 10.3390/ijms25063403.
3
Non-coding RNAs targeting NF-κB pathways in aquatic animals: A review.非编码 RNA 靶向水生动物 NF-κB 通路:综述。
Front Immunol. 2023 Feb 6;14:1091607. doi: 10.3389/fimmu.2023.1091607. eCollection 2023.
4
Small RNA Targets: Advances in Prediction Tools and High-Throughput Profiling.小RNA靶点:预测工具与高通量分析的进展
Biology (Basel). 2022 Dec 11;11(12):1798. doi: 10.3390/biology11121798.
5
Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma.肝细胞癌中microRNA-122的分子靶点及信号通路
Pharmaceutics. 2022 Jun 29;14(7):1380. doi: 10.3390/pharmaceutics14071380.
6
Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis.阐明新兴生物标志物早期预测肝纤维化的潜在抗纤维化机制。
Int J Mol Sci. 2020 Jul 3;21(13):4737. doi: 10.3390/ijms21134737.
7
Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease.犬大肠炎症性肠病中结肠黏膜和血清 microRNAs 的表达。
BMC Vet Res. 2020 Feb 22;16(1):69. doi: 10.1186/s12917-020-02287-6.
8
Plasma miR-146a predicts serological conversion of hepatitis B e-antigen (HBeAg) in chronic hepatitis B patients treated with nucleotide analogs.血浆 miR-146a 可预测接受核苷酸类似物治疗的慢性乙型肝炎患者乙肝 e 抗原(HBeAg)的血清学转换。
Ann Transl Med. 2019 Sep;7(18):449. doi: 10.21037/atm.2019.08.72.
9
Profiling the rainbow trout hepatic miRNAome under diet-induced hyperglycemia.在饮食诱导的高血糖条件下鉴定虹鳟鱼肝脏的 microRNA 组。
Physiol Genomics. 2019 Sep 1;51(9):411-431. doi: 10.1152/physiolgenomics.00032.2019. Epub 2019 Jul 8.
10
The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity.miRNAs 在肝脏疾病和毒性的病理生理学中的作用。
Int J Mol Sci. 2018 Jan 16;19(1):261. doi: 10.3390/ijms19010261.

本文引用的文献

1
microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma.microRNA-122 作为肝细胞癌中线粒体代谢基因网络的调节剂。
Mol Syst Biol. 2010 Aug 24;6:402. doi: 10.1038/msb.2010.58.
2
The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer.抑癌基因 p53:细胞过程的多效性主控因子和癌症治疗靶点
Biochem Biophys Res Commun. 2010 May 21;396(1):85-9. doi: 10.1016/j.bbrc.2010.02.152.
3
Linking the septin expression with carcinogenesis.将 septin 的表达与癌变联系起来。
Mol Biol Rep. 2010 Oct;37(7):3601-8. doi: 10.1007/s11033-010-0009-2. Epub 2010 Feb 27.
4
Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (<or=2 cm).肝细胞癌的蛋白质组学:血清波形蛋白可作为小肿瘤(<或=2 厘米)的替代标志物。
J Proteome Res. 2010 Apr 5;9(4):1923-30. doi: 10.1021/pr901085z.
5
AP-1--The Jun proteins: Oncogenes or tumor suppressors in disguise?AP-1——Jun 蛋白:伪装的癌基因还是抑癌基因?
Cell Signal. 2010 Jun;22(6):894-9. doi: 10.1016/j.cellsig.2009.12.008. Epub 2010 Jan 11.
6
IQGAP1 and vimentin are key regulator genes in naturally occurring hepatotumorigenesis induced by oxidative stress.IQGAP1 和波形蛋白是氧化应激诱导的自然发生肝肿瘤形成的关键调节基因。
Carcinogenesis. 2010 Mar;31(3):504-11. doi: 10.1093/carcin/bgp313. Epub 2009 Dec 16.
7
The ups and downs of Myc biology.Myc 生物学的兴衰。
Curr Opin Genet Dev. 2010 Feb;20(1):91-5. doi: 10.1016/j.gde.2009.11.001. Epub 2009 Dec 3.
8
Ensembl's 10th year.Ensembl 的第十个年头。
Nucleic Acids Res. 2010 Jan;38(Database issue):D557-62. doi: 10.1093/nar/gkp972. Epub 2009 Nov 11.
9
miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells.微小RNA-122影响肝癌细胞的活力和凋亡。
Scand J Gastroenterol. 2009;44(11):1332-9. doi: 10.3109/00365520903215305.
10
Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.用常见的临床病理参数预测根治性手术后肝细胞癌的预后。
BMC Cancer. 2009 Nov 3;9:389. doi: 10.1186/1471-2407-9-389.